Glucagonoma syndrome
References (31)
- et al.
Glucagonoma as part of the polyglandular adenoma syndrome
Am J Med
(1972) - et al.
Glucagon, gastrin, and carcinoid tumors of the duodenum, pancreas and stomach: Polypeptide “apudomas” of the foregut
Am J Surg
(1974) - et al.
Paraneoplastische dermatosen
Verh Dtsch Ges Inn Mcd
(1980) - et al.
Érytheme cutané migrateur avec nécrose épidermique superlicielle au cours d'une pancréatite chronique
Ann Derrnatol Venereol
(1974) - et al.
Necrolytic migratory erythema without glucagonoma
Arch Dermatol
(1979) - et al.
Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis: Possible pseudoglucagonoma syndrome
Br J Dermatol
(1979) - et al.
Angioplastic necrolytic migratory erythema: Unique association of necrolytic migratory erythema, extensive angioplasia, and high molecular weight glucagon-like polypeptide
Am J Dermatopathol
(1982) - et al.
The unlabeled antibody enzyme method of immunocytochemistry: Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes
J Histochem Cytochem
(1970) - et al.
The hyperglycemic, cutaneous syndrome: Pancreatic glucagonorna
Clinical and metabolic aspects of glucagonoma
Medicine
(1980)
Glucagonoma tumors and syndrome
Curr Probl Cancer
The glucagonoma syndrome: Clinical features, diagnosis and treatment
Endocr Rev
Operative and chemotherapeutic management of malignant glucagon-producing tumors
Surgery
Neurologic involvement in glucagonoma syndrome
Cancer
Necrolytic migratory erythema with carcinoma of the pancreas
Trans St Johns Hosp Dermatol SOC
Cited by (37)
Neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis
2011, Rheumatic Disease Clinics of North AmericaCitation Excerpt :Surgical removal of the tumor is the most effective treatment, which may produce rapid clinical resolution of the rash.63,70 Supplementation with zinc, amino acids, and essential fatty acids, and long-acting somatostatin analogues such as octreotide, may also be beneficial.71,72 Dermatomyositis (DM) is an idiopathic inflammatory myopathy often causing patients to present with characteristic cutaneous findings and proximal muscle weakness.
Metabolic and storage diseases
2009, Weedon's Skin Pathology: Third EditionLife-threatening paraneoplastic cutaneous syndromes
2005, Clinics in DermatologyNecrolytic migratory erythema as the only presenting sign of a glucagonoma
2003, Journal of the American Academy of DermatologyCutaneous manifestations of gastrointestinal diseases
2002, Dermatologic ClinicsThe glucagonoma syndrome: A review of its features and discussion of new perspectives
2001, American Journal of the Medical SciencesCitation Excerpt :Secondary infection by Candida species may be evident by hematoxylin-eosin or periodic acid-Schiff stain in lesions of longer duration. In the upper dermis, lesions generally manifest papillary edema, papillary vascular dilatation, and a sparse lymphohistiocytic, perivascular infiltrate.25,42,59 Direct and indirect immunofluorescence studies have been almost invariably negative.
Presented in part before the meeting of the Noah Worcester Dermatological Society, Hilton Head Island, SC, April 1–7, 1984.